Where are we now with hormone replacement therapy?

BMJ

Volumn 328, Issue 7436, 2004, Pages 357-358

  Mcpherson, Klim ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

BREAST CANCER; BREAST TUMOR; CANCER RISK; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; EDITORIAL; ENDOMETRIUM CANCER; FEMALE; HEALTH; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; IATROGENIC DISEASE; MENOPAUSAL SYNDROME; MENOPAUSE; PRIORITY JOURNAL;

BREAST NEOPLASMS; FEMALE; HEART DISEASES; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE;

EID: 1242273727     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.328.7436.357     Document Type: Editorial

References (12)

1. Barrett-Connor E. Cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women. J Clin End Met 2003; 88: 4031–42.
2. Writing Group for Women's Health Initiative Investigators. Risks and benefits of estrogen and progestin in healthy postmenopausal women: principal results from the women's health initiative randomised controlled trial. JAMA 2002; 288: 321–33.
3. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the million women study. Lancet 2003; 362: 419–27.
4. Studd J. Complications of hormone replacement therapy in postmenopausal women. J R Soc Med 1992; 85: 376–8.
5. Michels KB, Manson JE. Postmenopausal hormone therapy, a reversal of fortune. Circulation 2003; 107: 1830–3.
6. Sackett D. The arrogance of preventive medicine. JCMA 2002; 167: 363–4.
7. Herrington DM, Howard TD. From presumed benefit to potential harm—hormone therapy and heart disease. N Engl J Med 2003; 346: 519–21.
8. Bailar J. Hormone replacement therapy and cardiovascular diseases. N Engl J Med 2003; 339; 6: 521–2.
9. Minelli C, Abrams KK, Sutton AJ, Cooper NJ. Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ 2004; 328: 371–5.
10. Shapiro S. Risks of estrogen plus progestins therapy; a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial. Climacteric 2003; 6: 302–10.
11. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestins and the risks of coronary heart disease. N Engl J Med 2003; 349: 523–34.
12. Tucker G. Comments from reviewer. Climacteric 2003; 6: 310–4.